Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT02577965
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Registry
-
NCT02577965
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02577965. Randomized; double masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2012-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty: The OCTAVIA Trial
- Acronym
- OCTAVIA
- Condition
- Acute Myocardial Infarction
- Intervention (Procedure)
- Percutaneous Coronary Intervention
- Intervention (Device)
- XIENCE PRIME Everolimus Eluting Coronary Stent System
- Lead sponsor
- A.O. Ospedale Papa Giovanni XXIII
- Collaborator
- Light Lab Imaging, Inc.
Record details
- Record id
cardio:ct-nct02577965- Content hash
678c6b89a619a98337d07f8819cbd1e9260ea6a7c8a4025ab307f753df1a0fd1